Source: Eur Respir J 2012; 39: 265-271
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Bédard M-E., Brouillard C., Pepin V., Provencher S., Milot J., Lacasse Y., Leblanc P., Maltais F.. Tiotropium improves walking endurance in COPD. Eur Respir J 2012; 39: 265-271

Member's Comments

No comment yet.

Related content which might interest you: Endurance shuttle walking test: responsiveness to salmeterol in COPD Source: Eur Respir J 2008; 31: 579-584 Year: 2008 Differences between walking and stair climbing in severe COPD patients receiving and not receiving long-term NIV Source: Annual Congress 2007 - Physiological effects of noninvasive ventilation Year: 2007 Endurance shuttle walking test: response to salmeterol in chronic obstructive pulmonary disease Source: Annual Congress 2007 - Mechanisms and new treatments of COPD Year: 2007 Exercise and dyspnoea in COPD Source: Eur Respir Rev 2006; 15: 72-79 Year: 2006 Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 564-569 Year: 2002 Comparing interval and continuous endurance training in COPD Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention Year: 2005 Dynamic hyperinflation during the 6-minute walk test and incremental cycling exercise in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 121s Year: 2004 Effects of aclidinium bromide on exercise endurance, dynamic hyperinflation, physical activity and exertional dyspnoea in patients with moderate to severe COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Exercise training progression: assessing performance change Source: Annual Congress 2006 - PG18 - Basic principles of pulmonary rehabilitation Year: 2006 Salmeterol/fluticasone propionate (SFC) improves the inspiratory to total lung capacity ratio (IC/TLC) and exercise endurance time in patients with COPD Source: Annual Congress 2006 - COPD therapy Year: 2006 Change in 6 minute walk distance (6MWD) following a familiarisation test and exercise training in patients with chronic obstructive pulmonary disease (COPD): influence of disability Source: Annual Congress 2008 - Rehabilitation and influencing factors Year: 2008 Effect of 8 and 12 weeks’ once-daily tiotropium and olodaterol, alone and combined with exercise training, on exercise endurance during walking in patients with COPD Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Comparison of six-minute walking test and stair climbing test in mild to moderate chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 423s Year: 2003 Impacting patient-centred outcomes in COPD: deconditioning Source: Eur Respir Rev 2006; 15: 42-46 Year: 2006 Improvements in exercise endurance following pulmonary rehabilitation correlates with a reduction in dynamic hyperinflation Source: Annual Congress 2006 - Muscles, training and rehabilitation Year: 2006 Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD Source: Eur Respir J 2004; 23: 832-840 Year: 2004 Heliox, dyspnoea and exercise in COPD Source: Eur Respir Rev 2009; 19: 30-38 Year: 2010 Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD Source: Eur Respir J 2009; 34: 866-874 Year: 2009 Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD Source: Eur Respir J 2009; 33: 771-777 Year: 2009 Tiotropium as essential maintenance therapy in COPD Source: Eur Respir Rev 2006; 15: 51-57 Year: 2006